To compare the effective dose (E) of the Tru-Image® rectangular collimator and the universal round collimator of a Planmeca® wall-mounted radiograph unit for two bitewing radiographs (right and left) on a pediatric phantom.
Absorbed doses utilizing the Tru-Image ®rectangular collimator and universal round collimator were acquired using an anthropomorphic 10-year-old child phantom. Each set of 24 dosimeters was exposed to two bitewing exposures with the manufacturer's child settings. Fifty clinical exposures were completed for each set and three sets were exposed for each collimator. The average E per exposure was calculated.
The overall E for the Tru-Image ®rectangular collimator and the universal round collimator were 6.3 microsieverts (μSv) and 25.3 μSv, respectively. This difference was statistically significant ( <0.001). The highest equivalent dose for both collimators was delivered to the oral mucosa. When compared to the universal round collimator, the Tru-Image ® rectangular collimator had significant dose reduction at all locations ( <0.05). When normalized and adjusted to the same source-to-end distance, there was an overall 65 percent dose reduction with the rectangular collimator.
The average effective dose was significantly reduced with the use of the Tru-Image ®rectangular collimator. Clinical use of this rectangular collimator should be considered in the pediatric population.
Download full-text PDF |
Source |
---|
Data Brief
April 2024
Department für Kulturwissenschaften, Geschwister-Scholl-Platz 1, Ludwig-Maximilians-Universität München, München 80539, Germany.
Portable X-ray fluorescence (p-XRF) devices are commonly utilized to analyze the chemical composition of various materials, such as archaeological pottery and siliceous substances. The discussion regarding the suitability of this method for such samples is ongoing, as the data are often said to be quantitatively unreliable. Nevertheless, the development of coefficient corrections (coefcors) offers a means to transparently demonstrate the quality and comparability of p-XRF data.
View Article and Find Full Text PDFMed Phys
August 2024
Kavli Institute for the Physics and Mathematics of the Universe (IPMU) (WPI), The University of Tokyo Institutes for Advanced Study (UTIAS), The University of Tokyo, Kashiwa, Chiba, Japan.
Background: The recent emergence of targeted radionuclide therapy has increased the demand for imagers capable of visualizing pharmacokinetics in developing radiopharmaceuticals in the preclinical phase. Some radionuclides emit hard x-rays and gamma-rays below 100 keV, in which energy range the performance of conventional NaI scintillators is poor. Multipinhole collimators are also used for small animal imaging with a good spatial resolution but have a limited field of view (FOV).
View Article and Find Full Text PDFJ Appl Clin Med Phys
June 2024
Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Purpose: Patient-specific quality assurance (PSQA) for vertebra stereotactic body radiation therapy (SBRT) presents challenges due to highly modulated small fields with high-dose gradients between the target and spinal cord. This study aims to explore the use of the SRS MapCHECK® (SRSMC) for vertebra SBRT PSQA.
Methods: Twenty vertebra SBRT treatment plans including prescriptions 20 Gy/1 fraction and 24 Gy/2 fractions were selected for each of Millennium (M)-Multileaf Collimator (MLC), and high-definition (HD)-MLC.
Science
January 2024
Centre for Space Research, North-West University, Potchefstroom 2520, South Africa.
SS 433 is a microquasar, a stellar binary system that launches collimated relativistic jets. We observed SS 433 in gamma rays using the High Energy Stereoscopic System (H.E.
View Article and Find Full Text PDFBioengineering (Basel)
December 2023
Institute for Radiation Sciences, Osaka University, 1-1, Yamadaoka, Suita, Osaka 565-0871, Japan.
In targeted radionuclide therapy, determining the absorbed dose of the ligand distributed to the whole body is vital due to its direct influence on therapeutic and adverse effects. However, many targeted alpha therapy drugs present challenges for in vivo quantitative imaging. To address this issue, we developed a planar imaging system equipped with a cadmium telluride semiconductor detector that offers high energy resolution.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!